
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung c... Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.14 | 5.6129985229 | 20.31 | 22.47 | 20.01 | 1303181 | 21.60798196 | CS |
4 | 0.43 | 2.04567078972 | 21.02 | 24.03 | 19.52 | 1285756 | 20.88937862 | CS |
12 | 3.71 | 20.9131905299 | 17.74 | 24.03 | 17.445 | 998790 | 20.23878379 | CS |
26 | -7.385 | -25.6112363447 | 28.835 | 29.007 | 14.4 | 929941 | 20.69504946 | CS |
52 | -14.48 | -40.3005844698 | 35.93 | 47 | 14.4 | 951603 | 26.63808662 | CS |
156 | -4.14 | -16.1781946073 | 25.59 | 53.18 | 14.4 | 729457 | 31.92979752 | CS |
260 | 8.85 | 70.2380952381 | 12.6 | 57.2 | 9.59 | 702517 | 30.48070205 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.